SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-218870
Filing Date
2024-09-13
Accepted
2024-09-13 16:16:30
Documents
13
Period of Report
2024-09-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d806088d8k.htm   iXBRL 8-K 22650
  Complete submission text file 0001193125-24-218870.txt   139948

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20240910.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20240910_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20240910_pre.xml EX-101.PRE 10807
16 EXTRACTED XBRL INSTANCE DOCUMENT d806088d8k_htm.xml XML 3533
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 241297950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)